1. ScholarBank@NUS

Lingzhi Wang

rp05443

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
Main Affiliation
 
Faculty
 
Email
csiwl@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Author:  Goh, B.-C.
Date Issued:  [2010 TO 2019]

Results 1-10 of 10 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
12019A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinomaZhang, M.; Wang, B.; Chong, Q.-Y. ; Pandey, V.; Guo, Z.; Chen, R.-M.; Wang, L. ; Wang, Y.; Ma, L.; Kumar, A.P. ; Zhu, T.; Wu, Z.-S.; Yin, Z.; Basappa; Goh, B.-C. ; Lobie, P.E. 
2Sep-2010A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patientsWang, L.-Z. ; Chan, D.; Yeo, W.; Wan, S.-C.; Chan, S.; Chan, A.; Lee, S.-C.; Lee, H.-S.; Goh, B.-C.
3Jul-2013Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTan, T.Z.; Miow, Q.H.; Huang, R.Y.-J.; Wong, M.K.; Ye, J.; Lau, J.A.; Wu, M.C. ; Bin Abdul Hadi, L.H.; Soong, R. ; Choolani, M.; Davidson, B.; Nesland, J.M.; Wang, L.-Z. ; Matsumura, N.; Mandai, M.; Konishi, I.; Goh, B.-C.; Chang, J.T.; Thiery, J.P. ; Mori, S. 
430-Jan-2013Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer PatientsWang, L.-Z. ; Ramírez, J.; Yeo, W.; Chan, M.-Y.M.; Thuya, W.-L. ; Lau, J.-Y.A.; Wan, S.-C.; Wong, A.L.-A.; Zee, Y.-K.; Lim, R.; Lee, S.-C. ; Ho, P.C. ; Lee, H.-S.; Chan, A.; Ansher, S.; Ratain, M.J.; Goh, B.-C.
53-Aug-2012Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKLWen, Q.; Goldenson, B.; Silver, S.J.; Schenone, M.; Dancik, V.; Huang, Z.; Wang, L.-Z. ; Lewis, T.A.; An, W.F.; Li, X.; Bray, M.-A.; Thiollier, C.; Diebold, L.; Gilles, L.; Vokes, M.S.; Moore, C.B.; Bliss-Moreau, M.; Verplank, L.; Tolliday, N.J.; Mishra, R.; Vemula, S.; Shi, J.; Wei, L.; Kapur, R.; Lopez, C.K.; Gerby, B.; Ballerini, P.; Pflumio, F.; Gilliland, D.G.; Goldberg, L.; Birger, Y.; Izraeli, S.; Gamis, A.S.; Smith, F.O.; Woods, W.G.; Taub, J.; Scherer, C.A.; Bradner, J.E.; Goh, B.-C.; Mercher, T.; Carpenter, A.E.; Gould, R.J.; Clemons, P.A.; Carr, S.A.; Root, D.E.; Schreiber, S.L.; Stern, A.M.; Crispino, J.D.
65-Mar-2012Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Ong, R.Y.-L.; Chin, T.-M. ; Thuya, W.-L. ; Wan, S.-C.; Wong, A.L.A.; Chan, S.-Y. ; Ho, P.C. ; Goh, B.-C.
7Sep-2011Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteersWang, L. ; Soon, G.H.; Seng, K.-Y.; Li, J.; Lee, E.; Yong, E.-L.; Goh, B.-C.; Flexner, C.; Lee, L.
8Mar-2013Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Thuya, W.-L. ; Toh, D.S.-L.; Lie, M.G.-L.; Lau, J.-Y.A.; Kong, L.-R.; Wan, S.-C.; Chua, K.-N.; Lee, E.J.-D.; Goh, B.-C.
915-Jul-2011Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometryWang, L.-Z. ; Lim, M.Y.-X.; Chin, T.-M. ; Thuya, W.-L. ; Nye, P.-L.; Wong, A.; Chan, S.-Y. ; Goh, B.-C.; Ho, P.C. 
10Feb-2011Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric methodWang, L.-Z. ; Lee, L.S.-U.; Thuya, W.-L. ; Soon, G.H.; Kong, L.-R.; Nye, P.-L.; Deoon Lee, E.J.; Flexner, C.; Goh, B.-C.